Abstract: In an identification method, an analysis region in a test digital image is identified and values of a test parameter at a grid of locations in the analysis region are determined. A reference model of fixed pattern noise is associated with the test image. The reference model has an array of values of the test parameter for fixed pattern noise of a reference image acquisition device. A two or more dimensional similarity measure is calculated between the grid and at least a corresponding portion of the array.

Abstract: In a digital image matching method, reference calibration data associated with one or more reference digital image files is ascertained. The reference digital image files each have reference calibration data that is hidden metadata and can also have public metadata that is readable by a different procedure. A test digital image file is obtained and a data structure capable of holding the reference calibration data is detected in the test digital image file. The presence of second calibration data within the data structure of the test digital image file is determined. If the reference and second calibration data match, then the test digital image file and reference digital image files are from the same digital acquisition device.

Abstract: A novel solid pharmaceutical dispersion that improves the bioavailability of poorly water soluble drugs is produced by combining the drug with a polymer carrier such as polyvinylpyrrolidone. The drug is combined with the carrier without the need for using organic solvents or melting temperatures (fusion) through the use of a transition compound such as polyethylene glycol which partially solubilizes the drug and/or plasticizes the polymer.

Abstract: A novel solid pharmaceutical dispersion that improves the bioavailability of poorly water soluble drugs is produced by combining the drug with a polymer carrier such as polyvinylpyrrolidone. The drug is combined with the carrier without the need for using organic solvents or melting temperatures (fusion) through the use of a transition compound such as polyethylene glycol which partially solubilizes the drug and/or plasticizes the polymer.

Abstract: A novel solid pharmaceutical dispersion that improves the bioavailability of poorly water soluble drugs is produced by combining the drug with a polymer carrier such as polyvinylpyrrolidone. The drug is combined with the carrier without the need for using organic solvents or melting temperatures (fusion) through the use of a transition compound such as polyethylene glycol which partially solubilizes the drug and/or plasticizes the polymer.

Abstract: The cyclization, hydrolysis, and coloration of certain ACE inhibitors is minimized when they are formulated with a metal-containing stabilizer and a saccharide.